Amanote Research
Register
Sign In
PD-1 Blockade in GBM: Uncovering Response Clues
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nd2019-001
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 12, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
PD-1 Expression and Clinical PD-1 Blockade in B-Cell Lymphomas
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Non-Classical Estrogen Signaling Inhibits Melanoma and Improves Response to PD-1 Blockade
SSRN Electronic Journal
Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy
Oncolytic Virotherapy
PAK4 Inhibition Improves PD-1 Blockade Immunotherapy
Nature Cancer
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Breast Care
Surgery
Oncology
Clustering of Anti-GBM Disease: Clues to an Environmental Trigger?
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
TNFα Blockade Overcomes Resistance to Anti-Pd-1 in Experimental Melanoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
PD-1 Blockade in Renal Cell Carcinoma: To Equilibrium and Beyond
Cancer immunology research
Cancer Research
Immunology
PD-1 Blockade With Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
New England Journal of Medicine
Medicine
